Molecular diversity of VEGF-A as a regulator of its biological activity. - Test2 - elhamkhani - TriplyDB

Molecular diversity of VEGF-A as a regulator of its biological activity.

Molecular diversity of VEGF-A as a regulator of its biological activity.

http://www.wikidata.org/entity/Q34089123

about

Skeletal Blood Flow in Bone Repair and Maintenance A multiscale computational model predicts distribution of anti-angiogenic isoform VEGF165b in peripheral arterial disease in human and mouse The alternative heart: impact of alternative splicing in heart disease.Recombinant human VEGF165b inhibits experimental choroidal neovascularization The anti-angiogenic isoforms of VEGF in health and disease.New Insights into VEGF-A Alternative Splicing: Key Regulatory Switching in the Pathological Process Antagonizing the αv β3 integrin inhibits angiogenesis and impairs woven but not lamellar bone formation induced by mechanical loading.Low glucose microenvironment of normal kidney cells stabilizes a subset of messengers involved in angiogenesis.Angiogenesis and melanoma - from basic science to clinical trials.Prognostic value and in vitro biological relevance of Neuropilin 1 and Neuropilin 2 in osteosarcoma.VEGF111b, a C-terminal splice variant of VEGF-A and induced by mitomycin C, inhibits ovarian cancer growth.Ovarian VEGF(165)b expression regulates follicular development, corpus luteum function and fertility Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.Prokaryotic Soluble Overexpression and Purification of Human VEGF165 by Fusion to a Maltose Binding Protein Tag Regulatory SNPs and transcriptional factor binding sites in ADRBK1, AKT3, ATF3, DIO2, TBXA2R and VEGFA.Stability and Species Specificity of Renal VEGF-A Splicing Patterns in Kidney Disease.Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets FoxC1-dependent regulation of vascular endothelial growth factor signaling in corneal avascularity.Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF 165 b Isoform in the Vitreous of Patients with Retinopathy of Prematurity.The role of VEGF 165b in pathophysiology Physiological Capillary Regression is not Dependent on Reducing VEGF Expression.Exercise training and peripheral arterial disease.VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level.Autocrine VEGF Isoforms Differentially Regulate Endothelial Cell Behavior.The relationship between lymphatic vascular density and vascular endothelial growth factor A (VEGF-A) expression with clinical-pathological features and survival in pancreatic adenocarcinomas.Secretion of VEGF-165 has unique characteristics, including shedding from the plasma membrane.Vascular remodeling in cancer.Heparan sulfate in angiogenesis: a target for therapy.Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients.WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing.Airway basal cell vascular endothelial growth factor-mediated cross-talk regulates endothelial cell-dependent growth support of human airway basal cells.Effects of receptor tyrosine kinase inhibitors on VEGF165 a- and VEGF165 b-stimulated gene transcription in HEK-293 cells expressing human VEGFR2.A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy Real-time analysis of the binding of fluorescent VEGF165a to VEGFR2 in living cells: Effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor complexes Microvascular dysfunction: genetic polymorphisms suggest sex-specific differences in disease phenotype.VEGF may contribute to macrophage recruitment and M2 polarization in the decidua.AKT3, ANGPTL4, eNOS3, and VEGFA associations with high altitude sickness in Han and Tibetan Chinese at the Qinghai-Tibetan Plateau.Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2.VEGFA isoforms play a vital role in oral cancer progression.VEGFA SNPs and transcriptional factor binding sites associated with high altitude sickness in Han and Tibetan Chinese at the Qinghai-Tibetan Plateau

P2860

Q26825242-790D247C-5191-4107-9C7A-0063443E3F7A Q30275400-210E1D6C-9E4C-47B3-B1DE-53FCEDF3D6D2 Q30432053-8B40C79C-02B5-43C0-994D-F429C539FB65 Q33541827-D971B850-81B6-4B2F-8200-6557145C8DFA Q33901839-099B5E0E-3F94-4974-8DDD-AD5589439A0F Q34474159-FFC8E34C-ABA3-421C-8637-1D75618A4275 Q35068663-8C67FCE2-8E41-4EBB-88AD-3E373086B3F6 Q35294298-A3BD3CB6-F1E5-415F-A606-1E5C3D5ABCA6 Q35380959-3BB54E0D-9EFB-4E8F-9A07-F3F815387F95 Q35663028-5C00E6B3-2AD7-40C6-9FBA-B99A45DA08E1 Q35780939-6D65CB10-59FC-44F9-832C-BD800D9E705C Q35885946-FD8FD36A-C2D2-4CE2-85D5-45120049A32B Q35954103-46637451-774E-4FE0-AAEB-3B41681EF016 Q36032180-1096BEC4-E8E7-4E20-B8BD-2EFD90FA8C87 Q36088787-887B69A9-CE2E-4253-AF35-173BF7B5D173 Q36124029-15E82A47-A1C0-484E-AAC6-039C02566413 Q36158922-E9437715-B870-4ED1-9D15-454A9E22B7D6 Q36476460-B160911C-5446-4C25-B362-3FE32C178B51 Q36498533-9C5BB389-346D-4942-83DF-444ED03BAABE Q36542093-2E4B4B87-E1AE-49C7-AA37-E7C703767144 Q36552345-2A022F53-B140-4DC8-A515-C8DF8BE00B1E Q37157213-890C48A3-1ADD-4AD6-8D5B-527CEDFC28A3 Q37197773-FC66713F-95F5-4971-9166-7B4F1A555669 Q37270713-36C71E0C-D6B1-44A8-B54B-57F75F636530 Q37277702-93C6F7F0-AFA3-439C-875D-EFDD4FB3CE73 Q37669224-D135C449-C22B-4C80-96AD-1BA2C6109D85 Q38126351-EA37A61D-CEC1-44AB-85AC-428E5A564C58 Q38154506-067F10C3-5FB4-4FD5-8D20-E1E151F7AAD0 Q38620814-CF22F97B-FF47-493E-AA2B-C6B387074043 Q39427761-BC431552-74C5-4620-BA28-9A3D4DF900AD Q40016436-29AD3560-4028-4983-954E-EFD714429210 Q41432075-36B89E1E-2971-450A-805B-3B86CF33B4EA Q41574359-F8A800A1-CD29-49AD-9969-0D85692C2DD9 Q42076724-09F8294E-CBD7-4B06-BD14-A643B37C00F2 Q42643956-CF53A6C6-EBFF-4E40-BF0B-CE726EB80B13 Q50025011-439F14EF-F6B7-4250-8D08-84E8F871B4FF Q50508289-09ADB481-AB01-4E8A-985E-4E98B3EC1180 Q52717006-B4B90FFE-6F83-4338-B0EE-742B29F115DA Q53571593-57292DBF-A933-4EB3-8B36-7B7C103557A8 Q57097625-339CA1AD-035F-46F9-AD45-E8A716FD4B2E

P2860

Molecular diversity of VEGF-A as a regulator of its biological activity.

http://www.wikidata.org/entity/Q34089123

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Molecular diversity of VEGF-A as a regulator of its biological activity.

@ast

Molecular diversity of VEGF-A as a regulator of its biological activity.

@en

Molecular diversity of VEGF-A as a regulator of its biological activity.

@nl

type

label

Molecular diversity of VEGF-A as a regulator of its biological activity.

@ast

Molecular diversity of VEGF-A as a regulator of its biological activity.

@en

Molecular diversity of VEGF-A as a regulator of its biological activity.

@nl

prefLabel

Molecular diversity of VEGF-A as a regulator of its biological activity.

@ast

Molecular diversity of VEGF-A as a regulator of its biological activity.

@en

Molecular diversity of VEGF-A as a regulator of its biological activity.

@nl

P1433

Q34089123-C67C80C9-D866-4838-930E-1D5E6B4C66EB

P1476

Q34089123-EF9A5B62-9330-489A-9A6B-19443C14F90A

P2093

Q34089123-3ED6C0D7-AC1B-4E84-8EE3-903AEE410314

Q34089123-5D71403E-DCBC-4EB9-9A09-36FCE209A7D9

P2860

Q34089123-00AD7320-8811-44BD-BA53-5B39D2F59825

Q34089123-04551093-E39C-4ABC-90EC-D0CCE9EE7653

Q34089123-05B12184-443F-478A-91BA-9F1CE727E391

Q34089123-0B654F71-9AB6-444B-95AD-7400448E1773

Q34089123-0D4924B6-93F9-489B-BC3A-A04CC557E647

Q34089123-0EA41096-3B78-42C4-9CCE-644A959D1224

Q34089123-0EDC0B50-DC18-4A0D-8215-0A1087BC9711

Q34089123-11A63422-87E8-4DF7-B34F-E18F70123CD7

Q34089123-137BF388-B21E-40CD-88A1-A292A10A0F82

Q34089123-15040099-81D3-4DF0-9777-E0FCCEC591B0

P304

Q34089123-9C82F342-EEE6-4BB7-9C8A-E963D64A1C0C

P31

Q34089123-5C15E8F8-2A14-43BE-A2BB-D49BE2C3E4BC

P356

Q34089123-2DF00B83-12B1-4D46-8974-DDB10F0CF750

P433

Q34089123-E8F56601-0590-4CEC-ACB5-87D31943B17A

P478

Q34089123-1DA84C94-D567-46BA-9820-8CE071E3B7B1

P50

Q34089123-9426EC9F-6F65-439F-B990-121DE2DC8CBD

Q34089123-FDBC41AD-945F-48E9-A8A7-7D6560DC1274

P577

Q34089123-82A91474-B155-41CC-97A4-F13A3966039D

P5875

Q34089123-C397A093-D5E1-430B-BA83-3708CC29A5F7

P698

Q34089123-C1FD4553-6C73-4436-91C7-DB6EC2FDFD3D

P932

Q34089123-42F4945E-F050-497A-9923-717EDC4AD334

P356

10739680902997333

P1433

Microcirculation

P1476

Molecular diversity of VEGF-A as a regulator of its biological activity

@en

P2093

Heather S Bevan

http://www.w3.org/2001/XMLSchema#string

Steven J Harper

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residues

Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers

Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1

The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCgamma

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

P304

572-592

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10739680902997333

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Jeanette Woolard

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26287832

http://www.w3.org/2001/XMLSchema#string

P698

19521900

http://www.w3.org/2001/XMLSchema#string

P932

2929464

http://www.w3.org/2001/XMLSchema#string